The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $44.01

Today's change+0.38 +0.87%
Updated December 2 4:01 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $44.01

Today's change+0.38 +0.87%
Updated December 2 4:01 PM EST. Delayed by at least 15 minutes.

Baxter International Inc up (U.S.)$0.38

Baxter International Inc closed up Friday by (U.S.)$0.38 or 0.87% to (U.S.)$44.01. Shares have lost 5.80% over the last five days, but have gained 15.36% over the last year to date. This security has outperformed the S&P 500 by 12.39% during the last year.

Key company metrics

  • Open(U.S.) $43.78
  • Previous close(U.S.) $43.63
  • High(U.S.) $44.20
  • Low(U.S.) $43.69
  • Bid / Ask-- / --
  • YTD % change+15.36%
  • Volume5,933,939
  • Average volume (10-day)4,917,686
  • Average volume (1-month)4,913,990
  • Average volume (3-month)4,191,689
  • 52-week range(U.S.) $34.06 to (U.S.) $50.16
  • Beta0.83
  • Trailing P/E4.95×
  • P/E 1 year forward23.06×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $0.52
  • Dividend yield1.18%
  • Trailing EPS(U.S.) $8.89
Updated December 2 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,5582,5852,3752,603
Total other revenue--------
Total revenue2,5582,5852,3752,603
Gross profit1,0378559651,052
Total cost of revenue1,5211,7301,4101,551
Total operating expense2,3201,3695,3292,188
Selling / general / administrative611663620672
Research & development129150136158
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)59-1,1743,163-193
Other operating expenses, total--------
Operating income2381,216-2,954415
Interest income (expense), net non-operating-20-16-33-37
Gain (loss) on sale of assets--------
Other--------
Income before tax1281,2183,329205
Income after tax1271,2123,387183
Income tax, total16-5822
Net income1301,2123,380205
Total adjustments to net income--------
Net income before extra. items1271,2123,387183
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1271,2123,387183
Inc. avail. to common incl. extra. items1301,2123,380205
Diluted net income1301,2123,380205
Dilution adjustment--------
Diluted weighted average shares551553552552
Diluted EPS excluding extraordinary itemsvalue per share0.232.196.140.33
Dividends per sharevalue per share0.130.130.120.12
Diluted normalized EPSvalue per share0.18-0.0411.670.02